Dr. Kelly Killeen appeared on KTLA’s Good Day LA to discuss the recent Allergan Textured Implants recall and correlation to some ALCL cases.
In the past 2 years, there has been a lot of news coverage about breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). This disease is not breast cancer, but a type of non-Hodgkin’s lymphoma associated with breast implants.
The risk of developing this cancer if you have textured breast implants is one in 3,817 to one in 30,000. Since 2011, there have been 457 confirmed cases in the US, according to the Food and Drug Administration. There are more cases reported in Australia; the implants available in Australia are different from those sold in the United States. On July 24, 2019, Allergan has pulled their Biocell textured implants and tissue expanders from the worldwide market. This type of textured implants has shown the highest rates of ALCL.
Both Dr. Cassileth and Dr. Killeen have stopped using textured implants in their practice. Although these implants have benefits in certain patients, we became concerned about the increasing number of cases and unclear etiology of this rare cancer.